Medicine Injection Market

Chinese medicine injection is the product of the combination of traditional Chinese medicine theory and modern production technology, breaking through the traditional Chinese medicine administration method. There are more than 400 enterprises in the country producing 109 kinds of Chinese medicine injections.

Medicine Injection Market contains market size and forecasts of Chinese Medicine Injection in global, including the following market information:

Global Chinese Medicine Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Chinese Medicine Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Chinese Medicine Injection companies in 2021 (%)

The global Chinese Medicine Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Detoxification Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chinese Medicine Injection include Green Valley Pharma, Changbaishan Pharmaceutical, Zhejiang Kanglaite Pharmaceutical, Qingfeng Pharmaceutical Group, Buchang Pharmaceutical, Livzon, ZBD Pharmaceutical, Chase Sun Pharmaceutical and Wuzhou Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chinese Medicine Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chinese Medicine Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Chinese Medicine Injection Market Segment Percentages, by Type, 2021 (%)

Detoxification

Cardiovascular Disease Medication

Cerebrovascular Disease Medication

Anti-tumor Drugs

other

Global Chinese Medicine Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Chinese Medicine Injection Market Segment Percentages, by Application, 2021 (%)

Adult

Children

Global Chinese Medicine Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Chinese Medicine Injection Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chinese Medicine Injection revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Chinese Medicine Injection revenues share in global market, 2021 (%)

Key companies Chinese Medicine Injection sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Chinese Medicine Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Green Valley Pharma

Changbaishan Pharmaceutical

Zhejiang Kanglaite Pharmaceutical

Qingfeng Pharmaceutical Group

Buchang Pharmaceutical

Livzon

ZBD Pharmaceutical

Chase Sun Pharmaceutical

Wuzhou Pharmaceutical

Yusheng Pharmaceutical

Harbin Pharmaceutical Group

Fusen Pharmaceutical

Gerun Pharmaceutical

Shineway Pharmaceutical